1169942-85-1

Basic information

• Product Name: Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane
• Synonyms: Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane;bromo-triphenyl-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-$l^{5}-phosphane
• CAS NO: 1169942-85-1
• Molecular Formula: Br*C₃₁H₃₃BO₂P
• Molecular Weight: 559.281281
• Mol File: 1169942-85-1.mol
• Article Data: 6

Chemical Properties

• Melting Point: 265-270°C
• Appearance: /
• CAS DataBase Reference: Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane(CAS DataBase Reference)
• NIST Chemistry Reference: Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane(1169942-85-1)
• EPA Substance Registry System: Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane(1169942-85-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 1169942-85-1(Hazardous Substances Data)

Usage

Uses

Bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane (CAS# 1169942-85-1) is a lipogenic inhibitor for use in dyslipidemias and cancer. As a building block, bromotriphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)phosphorane can be fluorinated for use of imaging with positron emission tomography.

Upstream product

• 195062-57-8 p-tolylboronic pinacol ester 
• 73183-34-3 bis(pinacol)diborane 
• 624-31-7 4-tolyl iodide 
• 138500-85-3 4-bromomethylphenylboronic acid pinacol ester 
• 603-35-0 triphenylphosphine 

Downstream Products

• 1169942-94-2 4-{2-[4-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)-phenyl]-vinyl}-pyridine 
• 1394005-06-1 (Z)-3,5-di-tert-butyl-2-hydroxy-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 1169942-92-0 (E)-3,5-di-tert-butyl-2-hydroxy-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 1169942-91-9 (E)-4-(boronic acid)-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 868629-82-7 4,4,5,5-tetramethyl-2-{4-[2-(3,4,5-trimethoxyphenyl)-vinyl]-phenyl}-[1,3,2]dioxaborolane 
• 1169942-88-4 4,4,5,5-tetramethyl-2-{4-[2-(3,4,5-trimethoxyphenyl)-vinyl]-phenyl}-[1,3,2]dioxaborolane 
• 1221823-28-4 (Z)-4,4,5,5-tetramethyl-2-(4-styrylphenyl)-1,3,2-dioxaborolane 
• 943858-44-4 4,4,5,5-tetramethyl-2-[4-[(1E)-2-phenylethenyl]phenyl]-1,3,2-dioxaborolane 
• 1169942-90-8 2-{4-[2-(4-methoxy-phenyl)-vinyl]-phenyl}-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 1394005-07-2 (Z)-2-hydroxy-5-nitro-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 1169942-93-1 (E)-2-hydroxy-5-nitro-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 1169942-87-3 (E)-2-hydroxy-3,5-dichloro-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 1333375-03-3 (E)-2-hydroxy-3,5-dichloro-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)stilbene 
• 1169942-95-3 4,4,5,5-tetramethyl-2-{4-[2-(3,4,5-trimethoxyphenyl)-vinyl]-phenyl}-[1,3,2]dioxaborolane 

Relevant articles and documents

DRUG AND GENE THERAPY TO TREAT HIGH MYOPIA AND OTHER OCULAR DISORDERS WITH ENLARGED EYE GLOBES

This invention relates to a treatment of various eye conditions relating to eye enlargement. The conditions can be treated by inhibiting an upstream protein within the said biological pathway or by increasing the expression of a downstream receptor within

Design and synthesis of boron containing potential pan-RAR inverse agonists

We designed and successfully synthesized the compounds 5 and 8 as potential pan-RAR (retinoic acid receptor) agonists. These two compounds were designed based on an existing pan-RAR agonist (BMS493). We synthesized compound 5, in which the carboxylic acid

Boronated phosphonium salts containing arylboronic acid, closo-carborane, or nido-carborane: Synthesis, X-ray diffraction, in vitro cytotoxicity, and cellular uptake

The preparation of boronated triaryl and tetraaryl phosphonium salts of the type [PPh3CH2R]Br [R is 4-boronophenyl (1), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-yl)phenyl (2), 3-boronophenyl (3), 3-(4,4,5,5-tetramethyl-1,3,2-dioxabo